Search

everythinglearnresearchcommunity

for

Search:↓

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Human hair follicles have a unique metabolism that changes between growth stages and may contribute to baldness.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

The conclusion is that skin and hair patterns are formed by a mix of cell activities, molecular signals, and environmental factors.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Some skin diseases and their treatments can negatively affect male fertility.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

New treatments for PCOS focus on managing symptoms and improving fertility.